Post placeholder image
January 6, 2026 in Home Page, NanOlogy Press Release

NanOlogy Appoints John M. Goldberg, MD as Chief Medical Officer to Further its Preclinical & Clinical Large Surface Area Microparticle Investigational Drug Portfolio

PRESS RELEASENanOlogy Appoints John M. Goldberg, MD as Chief Medical Officer to Further its Preclinical & Clinical Large Surface Area Microparticle Investigational Drug PortfolioFORT WORTH, Texas ...

Read More